BMY price target
Bristol-Myers Squibb Company · end-of-day data as of Oct 16, 2026
Bristol-Myers Squibb Company
$59.75-2.8%
Hold · 30 analystsPT $65.38 +9.4%
The average price target of the 16 analyst firms that published one in the last 12 months is $65.38 for BMY, 9.4% above the last close of $59.75 on Oct 16, 2026. Targets range from $41.00 to $81.00, with a median of $64.63. Rating consensus: Hold.
Summary
- Target upside+9.4%
- ConsensusHold
Analyst price targets
Low$41.00
Average$65.38
Median$64.63
High$81.00
Upside+9.4%
16 firms with a target in the last 12 months · last close $59.75 · as of Oct 16, 2026
Wells Fargo$612026-02-06
Piper Sandler$632026-01-28
Leerink Partners$582026-01-13
Scotiabank$582026-01-09
UBS$632026-01-07
Guggenheim$612025-12-12
+3 more
Morgan Stanley$352025-12-12
UBS$682026-03-06
Piper Sandler$732026-02-23
Barclays$732026-02-19
Guggenheim$732026-02-06
Morgan Stanley$392026-02-06
Cantor Fitzgerald$532026-04-08
RBC Capital$582026-02-24
Goldman Sachs$612026-09-23
HSBC$642026-09-10
Argus Research$722026-08-05
Roth Capital$742026-08-05
RBC Capital$642026-08-04
Cantor Fitzgerald$602026-07-31
+1 more
Guggenheim$752026-07-31
Jefferies$762026-10-12
Piper Sandler$812026-09-16
Cantor Fitzgerald$532026-10-08
Leerink Partners$592026-10-05
Morgan Stanley$412026-10-07
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 4 · Buy 7 · Hold 18 · Sell 1 · Strong sell 0